Sean Khozin

Real-world Data for Clinical Evidence Generation in Oncology

Sean Khozin, Gideon M. Blumenthal, Richard Pazdur · JNCI Journal of the National Cancer Institute · 2017 · 332 citations · Full text

Clinical Endpoint, Real-world Evidence, Cancer Registration +22

Developing and adopting safe and effective digital biomarkers to improve patient outcomes

Andrea Coravos, Sean Khozin, Kenneth D. Mandl · npj Digital Medicine · 2019 · 314 citations · Full text

FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer

Sean Khozin, Gideon M. Blumenthal, Lijun Zhang et al. · Clinical Cancer Research · 2015 · 182 citations

Pathology, Fda Approval, Pharmacotherapy +16

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer

Ronan J. Kelly, Anish Thomas, Arun Rajan et al. · Annals of Oncology · 2013 · 171 citations · Full text

Phase I/ii Study, Medicine, Pharmacology +8

Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer

Gideon M. Blumenthal, Yuexuan Gong, Kenneth L. Kehl et al. · Annals of Oncology · 2019 · 151 citations

Time-to-treatment Discontinuation, Medicine, Clinical Trials +10